Bioactive Compounds
-
N2892 PristaneSummary: A compound that can be used to induce animal models of rheumatoid arthritis and systemic lupus erythematosus-like syndrome. -
C8752 SEL120-34A hydrochlorideSummary: An ATP-competitive inhibitor of CDK8/CDK19 -
C8753 Ceftolozane sulfateSummary: A time-dependent oxyimino cephalosporin antibacterial agent that inhibits bacterial penicillin-binding proteins (PBP3 as the primary target). -
C8754 KR-12 (human) TFASummary: The smallest antimicrobial active fragment of the human antimicrobial peptide LL-37 (corresponding to amino acids 18–29 of LL-37) -
C8755 Taltirelin acetateSummary: A TRH receptor 1 (TRHR1) agonist -
C8756 CHI3L1-IN-5Summary: A CHI3L1 inhibitor -
C8757 PAD4-IN-2 TFASummary: A PAD4 inhibitor -
C8758 2-Bromohexadecanoic acidSummary: A DHHC family palmitoyltransferase (PAT) inhibitor; pyroptosis inhibitor -
C8759 Indole-3-pyruvic acidSummary: A key metabolite of tryptophan, serves as a core intermediate in the biosynthesis of IAA, and acts as an activator of the aryl hydrocarbon receptor (AhR). -
C8760 PDK4-IN-1 hydrochlorideSummary: An effective, highly selective, orally active pyruvate dehydrogenase kinase 4 (PDK4) inhibitor.